# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed Feb 13, 2025

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2025-02-13
- Accepted by EDGAR: Feb 13, 2025, 08:09 ET
- Period: 2025-02-13
- Accession: 0001178670-25-000020
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000117867025000020/alny-20250213.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000117867025000020/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000117867025000020/alny-20250213.htm

Filed Feb 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001178670-25-000020. Last ingested by Listed: Nov 14, 2026, 23:27 ET. No prices; not investment advice.
